These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Therapeutic peptide vaccines for treatment of autoimmune diseases. Wraith DC Immunol Lett; 2009 Feb; 122(2):134-6. PubMed ID: 19100774 [TBL] [Abstract][Full Text] [Related]
6. Protection against autoimmunity in nonlymphopenic hosts by CD4+ CD25+ regulatory T cells is antigen-specific and requires IL-10 and TGF-beta. Huang X; Zhu J; Yang Y J Immunol; 2005 Oct; 175(7):4283-91. PubMed ID: 16177068 [TBL] [Abstract][Full Text] [Related]
7. Oral tolerance: elucidation of mechanisms and application to treatment of autoimmune diseases. Fowler E; Weiner HL Biopolymers; 1997; 43(4):323-35. PubMed ID: 9316395 [TBL] [Abstract][Full Text] [Related]
8. Autoimmunity: basic mechanisms and implications in endocrine diseases. Part II. Ballotti S; Chiarelli F; de Martino M Horm Res; 2006; 66(3):142-52. PubMed ID: 16807509 [TBL] [Abstract][Full Text] [Related]
9. CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. Suri-Payer E; Amar AZ; Thornton AM; Shevach EM J Immunol; 1998 Feb; 160(3):1212-8. PubMed ID: 9570536 [TBL] [Abstract][Full Text] [Related]
10. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Tang Q; Adams JY; Tooley AJ; Bi M; Fife BT; Serra P; Santamaria P; Locksley RM; Krummel MF; Bluestone JA Nat Immunol; 2006 Jan; 7(1):83-92. PubMed ID: 16311599 [TBL] [Abstract][Full Text] [Related]
11. Oral tolerance. Weiner HL; da Cunha AP; Quintana F; Wu H Immunol Rev; 2011 May; 241(1):241-59. PubMed ID: 21488901 [TBL] [Abstract][Full Text] [Related]
13. Autoantigen-specific TGFbeta-induced Foxp3+ regulatory T cells prevent autoimmunity by inhibiting dendritic cells from activating autoreactive T cells. DiPaolo RJ; Brinster C; Davidson TS; Andersson J; Glass D; Shevach EM J Immunol; 2007 Oct; 179(7):4685-93. PubMed ID: 17878367 [TBL] [Abstract][Full Text] [Related]
14. [Application of oral tolerance to the treatment of autoimmune diseases--active suppression and bystander suppression]. Matsui M Nihon Rinsho; 1997 Jun; 55(6):1537-42. PubMed ID: 9200945 [TBL] [Abstract][Full Text] [Related]
15. Advantage of having regulatory T cells requires localized suppression of immune reactions. Saeki K; Iwasa Y J Theor Biol; 2009 Oct; 260(3):392-401. PubMed ID: 19563814 [TBL] [Abstract][Full Text] [Related]
16. The role of autoantigens in autoimmune disease. Mocci S; Lafferty K; Howard M Curr Opin Immunol; 2000 Dec; 12(6):725-30. PubMed ID: 11102779 [TBL] [Abstract][Full Text] [Related]
17. Expanding antigen-specific regulatory networks to treat autoimmunity. Clemente-Casares X; Blanco J; Ambalavanan P; Yamanouchi J; Singha S; Fandos C; Tsai S; Wang J; Garabatos N; Izquierdo C; Agrawal S; Keough MB; Yong VW; James E; Moore A; Yang Y; Stratmann T; Serra P; Santamaria P Nature; 2016 Feb; 530(7591):434-40. PubMed ID: 26886799 [TBL] [Abstract][Full Text] [Related]
18. Prevention of type 1 diabetes. Rabinovitch A; Skyler JS Med Clin North Am; 1998 Jul; 82(4):739-55. PubMed ID: 9706119 [TBL] [Abstract][Full Text] [Related]
19. Regulatory T cells in health and disease. Rouse BT J Intern Med; 2007 Jul; 262(1):78-95. PubMed ID: 17598816 [TBL] [Abstract][Full Text] [Related]
20. Evidence for extrathymic generation of regulatory T cells specific for a retinal antigen. Gregerson DS; Heuss ND; Lehmann U; McPherson SW Ophthalmic Res; 2008; 40(3-4):154-9. PubMed ID: 18421231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]